The tumor-suppressive function of DLC1 can largely be attributed to its four functional domains: a sterile alpha motif (SAM) at the NH2 terminal, a focal adhesion targeting region, a RhoGAP domain, and a steroidogenic acute regulatory protein related lipid-transfer (START) at the COOH terminal. This evidence concerns the gene DLC1 and neoplasm.